- Home
- NEUE
NEUE
NEUEHEALTH INC
as 05-30-2025 4:00pm EST
Stocks
NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | DORAL |
| Market Cap: | 61.2M | IPO Year: | 2021 |
| Target Price: | $7.00 | AVG Volume (30 days): | 7.2K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -21.88 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.79 - $7.66 | Next Earning Date: | 05-08-2025 |
| Revenue: | $907,349,000 | Revenue Growth: | -17.91% |
| Revenue Growth (this year): | 33.99% | Revenue Growth (next year): | 5.90% |
Stock Insider Trading Activity of NEUEHEALTH INC (NEUE)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Scherman Jeffrey J | NEUE | Chief Accounting Officer | May 12 '25 | Sell | $6.76 | 112 | $757.12 | 12,463 | |
| Matushak Jay | NEUE | Chief Financial Officer | May 12 '25 | Sell | $6.76 | 472 | $3,190.72 | 40,556 | |
| Orozco Tomas | NEUE | EVP, Consumer Care | Mar 13 '25 | Sell | $6.44 | 4,766 | $31,374.98 | 30,551 | |
| Craig Jeffery Michael | NEUE | GC & Corporate Secretary | Mar 13 '25 | Sell | $6.44 | 3,494 | $23,001.17 | 20,104 | |
| Scherman Jeffrey J | NEUE | Chief Accounting Officer | Mar 13 '25 | Sell | $6.44 | 1,373 | $9,038.69 | 12,463 | |
| Mikan George Lawrence III | NEUE | CEO & President | Mar 13 '25 | Sell | $6.44 | 48,336 | $318,196.24 | 261,894 | |
| Matushak Jay | NEUE | Chief Financial Officer | Mar 13 '25 | Sell | $6.44 | 5,990 | $39,431.98 | 40,556 | |
| Orozco Tomas | NEUE | EVP, Consumer Care | Mar 11 '25 | Sell | $6.89 | 1,917 | $13,235.45 | 30,551 | |
| Craig Jeffery Michael | NEUE | GC & Corporate Secretary | Mar 11 '25 | Sell | $6.89 | 1,148 | $7,940.04 | 20,104 | |
| Scherman Jeffrey J | NEUE | Chief Accounting Officer | Mar 11 '25 | Sell | $6.89 | 802 | $5,523.70 | 12,463 |
Latest NEUEHEALTH INC News
NEUE Breaking Stock News: Dive into NEUE Ticker-Specific Updates for Smart Investing
GuruFocus.com
23 days ago
NeueHealth Inc (NEUE) Q1 2025 Earnings Call Highlights: Strong Consumer Growth and Continued ...
Business Wire
24 days ago
NeueHealth Reports First Quarter 2025 Results
Business Wire
a month ago
NeueHealth to Host First Quarter 2025 Earnings Conference Call on May 8, 2025
Business Wire
2 months ago
NeueHealth Reports Fourth Quarter and Full Year 2024 Results
Business Wire
3 months ago
NeueHealth to Host Fourth Quarter 2024 Earnings Conference Call on March 20, 2025
Business Wire
5 months ago
NeueHealth to Be Taken Private by NEA and Consortium of Investors
Simply Wall St.
7 months ago
NeueHealth Third Quarter 2024 Earnings: US$6.78 loss per share (vs US$72.52 loss in 3Q 2023)
Business Wire
7 months ago
Neuehealth Reports Third Quarter 2024 Results
Compare NEUE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NEUE NEUEHEALTH INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.